statistiche ricercatore

Continente	#
AS - Asia	1.446
NA - Nord America	1.077
EU - Europa	304
SA - Sud America	52
Continente sconosciuto - Info sul continente non disponibili	24
AF - Africa	11
OC - Oceania	1
Totale	2.915

Nazione	#
HK - Hong Kong	1.095
US - Stati Uniti d'America	1.062
SG - Singapore	140
IT - Italia	108
CN - Cina	71
UA - Ucraina	58
VN - Vietnam	50
BR - Brasile	47
RU - Federazione Russa	38
DE - Germania	23
IN - India	22
TR - Turchia	21
IE - Irlanda	16
SE - Svezia	14
FI - Finlandia	13
FR - Francia	12
KR - Corea	11
CA - Canada	6
IQ - Iraq	6
JP - Giappone	6
ES - Italia	5
GB - Regno Unito	5
PK - Pakistan	5
BD - Bangladesh	4
AR - Argentina	3
AT - Austria	3
CR - Costa Rica	3
MX - Messico	3
SA - Arabia Saudita	3
TN - Tunisia	3
ZA - Sudafrica	3
AE - Emirati Arabi Uniti	2
EG - Egitto	2
NL - Olanda	2
PL - Polonia	2
AL - Albania	1
AU - Australia	1
AZ - Azerbaigian	1
BB - Barbados	1
CH - Svizzera	1
ET - Etiopia	1
ID - Indonesia	1
IL - Israele	1
JM - Giamaica	1
JO - Giordania	1
KE - Kenya	1
KH - Cambogia	1
KZ - Kazakistan	1
LT - Lituania	1
MO - Macao, regione amministrativa speciale della Cina	1
MY - Malesia	1
NI - Nicaragua	1
PH - Filippine	1
RO - Romania	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
TH - Thailandia	1
UY - Uruguay	1
VE - Venezuela	1
Totale	2.891

Nome	#
[Hemodynamic properties of nebivolol].	547
Association of suboptimal blood pressure control with body size and metabolic abnormalities	390
Serum uric acid and left ventricular mass in essential hypertension	261
Risk factors and acute ischemic stroke subtypes	200
Nutraceuticals for treatment of high blood pressure values in patients with metabolic syndrome	182
Smoking Selectively Accelerates Carotid Atherosclerosis in Hypertensive Patients	179
Does information on systolic and diastolic function improve prediction of a cardiovascular event by left ventricular hypertrophy in arterial hypertension?	177
Persistence and adherence to antihypertensive treatment in relation to initial prescription: diuretics versus other classes of antihypertensive drugs.	170
Clinical evidence of efficacy of red yeast rice and berberine in a large controlled study versus diet	163
Functional foods and cardiometabolic diseases: International Task Force for Prevention of Cardiometabolic Diseases.	145
Therapy, Pharmacoeconomics and Pharmacovigilance	134
Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus.	127
Usefulness of a telematic system and image analysis in the follow-up of high-risk patients: a new health service model	122
Renin-angiotensin system modulation: instructions for use	118
Totale	2.915

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	90	0	0	0	0	3	3	3	1	12	13	13	42
2022/2023	193	16	29	3	22	26	33	0	16	42	0	5	1
2023/2024	51	9	2	2	3	2	12	0	2	0	4	1	14
2024/2025	176	3	3	0	6	2	28	48	8	18	11	21	28
2025/2026	1.646	86	543	523	18	130	30	99	22	47	66	12	70
2026/2027	94	16	18	30	30	0	0	0	0	0	0	0	0
Totale													2.915

UniSa - IRIS Institutional Research Information System